I agree that this site is using cookies. You can find further informations here.
X
Han, Htay Htay
101  results:
Search for persons X
?
1

SCB-2019 protein vaccine as heterologous booster of neutral..:

Roa Jr., Camilo C. ; de Los Reyes, Mari Rose A. ; Plennevaux, Eric...
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

Safety and immunogenicity of SCB-2019, an adjuvanted, recom..:

Lopez, Pio ; Bravo, Lulu ; Buntinx, Erik...
Human Vaccines & Immunotherapeutics.  19 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
3

Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-prote..:

Buntinx, Erik ; Brochado, Leonardo ; Borja-Tabora, Charissa...
Vaccine.  41 (2023)  11 - p. 1875-1884 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Efficacy of the adjuvanted subunit protein COVID-19 vaccine..:

Bravo, Lulu ; Smolenov, Igor ; Han, Htay Htay...
The Lancet.  399 (2022)  10323 - p. 461-472 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Safety and immunogenicity of S-Trimer (SCB-2019), a protein..:

Richmond, Peter ; Hatchuel, Lara ; Dong, Min...
The Lancet.  397 (2021)  10275 - p. 682-694 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine..:

Ambrosino, Donna ; Han, Htay Htay ; Hu, Branda...
The Journal of Infectious Diseases.  225 (2021)  2 - p. 327-331 , 2021
Link: https://doi.org/10.1093/..
 
?
7

Persistence of the Immune Responses and Cross-Neutralizing ..:

Richmond, Peter C ; Hatchuel, Lara ; Pacciarini, Filippo...
The Journal of Infectious Diseases.  , 2021
Link: https://doi.org/10.1093/..
 
?
8

Safety and immunogenicity of experimental stand-alone triva..:

Cramer, Jakob P. ; Jimeno, José ; Han, Htay Htay...
Vaccine.  38 (2020)  33 - p. 5313-5323 , 2020
Link: https://doi.org/10.1016/..
 
?
9

A phase III, open-label, randomised multicentre study to ev..:

Marlow, Robin ; Kuriyakose, Sherine ; Mesaros, Narcisa...
Vaccine.  36 (2018)  17 - p. 2300-2306 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Serologic response to porcine circovirus type 1 (PCV1) in i..:

Han, Htay Htay ; Karkada, Naveen ; Jayadeva, Girish.
Human Vaccines & Immunotherapeutics.  13 (2017)  1 - p. 237-244 , 2017
Link: https://doi.org/10.1080/..
 
?
11

Post-marketing safety surveillance conducted in Korea (2008..:

Shin, Son Moon ; Kim, Chun Soo ; Karkada, Naveen...
Human Vaccines & Immunotherapeutics.  12 (2016)  10 - p. 2590-2594 , 2016
Link: https://doi.org/10.1080/..
 
?
12

Immunogenicity and safety of 3-dose primary vaccination wit..:

Lalwani, Sanjay K. ; Agarkhedkar, Sharad ; Sundaram, Balasubramanian...
Human Vaccines & Immunotherapeutics.  13 (2016)  1 - p. 120-127 , 2016
Link: https://doi.org/10.1080/..
 
?
13

The safety and reactogenicity of a reduced-antigen-content ..:

Anh, Dang Duc ; Jayadeva, Girish ; Kuriyakose, Sherine.
Vaccine.  34 (2016)  37 - p. 4360-4363 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Incidence of rotavirus gastroenteritis by age in African, A..:

Steele, A. Duncan ; Madhi, Shabir A. ; Cunliffe, Nigel A....
Human Vaccines & Immunotherapeutics.  12 (2016)  9 - p. 2406-2412 , 2016
Link: https://doi.org/10.1080/..
 
?
15

Safety and reactogenicity of the combined diphtheria-tetanu..:

Anh, Dang Duc ; Van Der Meeren, Olivier ; Karkada, Naveen...
Human Vaccines & Immunotherapeutics.  12 (2015)  3 - p. 655-657 , 2015
Link: https://doi.org/10.1080/..
 
1-15